TaiGen Biotechnology Company, announced today that it has filed an IND application with the US FDA for its influenza antiviral TG-1000.

Too often, patients needing Post Acute Care do not have the critical information they need to carefully assess their options and make informed choices

With the rise of the COVID19 pandemic, many of us have an increasing volume of work interactions mediated through computer screens. Collaboration accelerates care decisions.

This nation spends way too much on healthcare; $3.7 trillion annually. America may be the land of the free, but it is also becoming the home of the chronically ill.